References
- Abbas NF, Labib El-Sharkawy S, Abbas EA, Abdel Monem El-Shaer M (2007). Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103, 385-90. https://doi.org/10.1016/j.tripleo.2005.11.008
- Angiero F, Berenzi A, Benetti A, et al (2008). Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity. Anticancer Res, 28, 2535-9.
- Ayan N, Ayan I, Alatli C, et al (2000). p53 overexpression in normal oral mucosa of heavy smokers. J Exp Clin Cancer Res, 19, 525-29.
- Bishen KA, Radhakrishnan R, Satyamoorthy K (2008). The role of basic fibroblast growth factor in oral submucous fibrosis pathogenesis. J Oral Pathol Med, 37, 402-11. https://doi.org/10.1111/j.1600-0714.2008.00649.x
- Chiang CP, Lang MJ, Liu BY, et al (2000). Expression of p53 protein in oral sub mucous fibrosis, oral epithelial hyperkeratosis, and oral epithelial dysplasia. J Formos Med Assoc, 99, 229-34.
- Cornacchio AL, Burneo JG, Aragon CE (2011). The effects of antiepileptic drugs on oral health. J Can Dent Assoc, 77, b140.
- Correa JD, Queiroz-Junior CM, Costa JE, Teixeira AL, Silva TA (2011). Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features. ISRN Dent, 497850.
- Haque MF, Harris M, Meghji S, Barrett AW (1998). Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine, 10, 713-9. https://doi.org/10.1006/cyto.1997.0342
- Heah KG, Hassan MI, Huat SC (2011). p53 Expression as a marker of microinvasion in oral squamous cell carcinoma. Asian Pac J Cancer Prev, 12, 1017-22.
- Kaplan I, Vered M, Moskona D, Buchner A, Dayan D (1998). An immunohistochemical study of p53 and PCNA in inflammatory papillary hyperplasia of the palate: a dilemma of interpretation. Oral Dis, 4, 194-99.
-
Khan I, Agarwal P, Thangjam GS, et al (2011). Role of TGF-
${\beta}$ and BMP7 in the pathogenesis of oral submucous fibrosis. Growth Factors, 29, 119-27. https://doi.org/10.3109/08977194.2011.582839 - Kuo MY, Chang HH, Hahn LJ, Wang JT, Chiang CP (1995). Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinoma in Taiwan. J Oral Pathol Med, 24, 255-60. https://doi.org/10.1111/j.1600-0714.1995.tb01178.x
- Lucchesi JA, Cortelli SC, Rodrigues JA, Duarte PM (2008). Severe phenytoin-induced gingival enlargement associated with periodontitis. Gen Dent, 56, 199-203
- McLoughlin P, Newman L, Brown A (1995). Oral squamous cell carcinoma arising in phenytoin-induced hyperplasia. Br Dent J, 178, 183-84. https://doi.org/10.1038/sj.bdj.4808698
- Murugan AK, Munirajan AK, Tsuchida N (2012). Ras oncogenes in oral cancer: the past 20 years. Oral Oncol, 48, 383-92. https://doi.org/10.1016/j.oraloncology.2011.12.006
- Nasser W, Flechtenmacher C, Holzinger D, Hofele C, Bosch FX (2011). Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias. J Oral Pathol Med, 40, 629-35. https://doi.org/10.1111/j.1600-0714.2011.01026.x
- Pahor M, Guralnik JM, Ferrucci L, et al (1996). Calcium-channel blockade and incidence of cancer in aged populations. Lancet, 348, 493-97. https://doi.org/10.1016/S0140-6736(96)04277-8
- Pai R, Pai S, Lalitha R, et al (2009). Over-expression of c-Myc oncoprotein in oral squamous cell carcinoma in the South Indian population. Ecancermedicalscience, 3, 128.
- Ranganathan K, Kavitha R (2011). Proliferation and apoptosis markers in oral submucous fibrosis. J Oral Maxillofac Pathol, 15, 148-53. https://doi.org/10.4103/0973-029X.84478
- Saito K, Mori S, Tanda N, Sakamoto S (1999). Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin. J Perio, 70, 581-86. https://doi.org/10.1902/jop.1999.70.6.581
- Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM (2010). A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomarkers Prev, 19, 574-87. https://doi.org/10.1158/1055-9965.EPI-09-0981
- Varga E, Tyldesley WR (1991). Carcinoma arising in cyclosporininduced gingival hyperplasia. Br Dent J, 171, 26-27. https://doi.org/10.1038/sj.bdj.4807594
- Wakulich C, Jackson-Boeters L, Daley TD, Wysocki GP (2002). Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 93, 573-9. https://doi.org/10.1067/moe.2002.124461
- Wells PG, Kim PM, Laposa RR, et al (1997). Oxidative damage in chemical teratogenesis. Mutation Res, 396, 65-78. https://doi.org/10.1016/S0027-5107(97)00175-9
Cited by
- A Novel Heterozygous Mutation (F252Y) in Exon 7 of the IRF6 Gene is Associated with Oral Squamous Cell Carcinomas vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.6803
- Lack of RING Finger Domain (RFD) Mutations of the c-Cbl Gene in Oral Squamous Cell Carcinomas in Chennai, India vol.14, pp.2, 2013, https://doi.org/10.7314/APJCP.2013.14.2.1073
- Tyrosine 1045 Codon Mutations in Exon 27 of EGFR are Infrequent in Oral Squamous Cell Carcinomas vol.14, pp.7, 2013, https://doi.org/10.7314/APJCP.2013.14.7.4279
- Mining Proteins Associated with Oral Squamous Cell Carcinoma in Complex Networks vol.14, pp.8, 2013, https://doi.org/10.7314/APJCP.2013.14.8.4621
- Mutation Analysis of the Dimer Forming Domain of the Caspase 8 Gene in Oral Submucous Fibrosis and Squamous Cell Carcinomas vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4589
- Detection of p53 and Bcl-2 expression in cutaneous hemangioma through the quantum dot technique vol.13, pp.5, 2017, https://doi.org/10.3892/ol.2017.5856